Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
A total of 332 patients entered the study and 277 patients were randomised and treated, 137 with FP250µg twice daily via Diskus TM inhaler and 140 with budesonide 600µg twice daily via ...
GSK said it plans to file its once daily closed triple combination therapy of fluticasone furoate, umeclidinium ... with AZ's Symbicort Turbohaler (budesonide+formoterol) in lung function measured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback